Complications of Recombinant Human BMP-2 for Treating Complex Tibial Plateau Fractures: A Preliminary Report
- 20 August 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Orthopaedics and Related Research®
- Vol. 467 (12), 3257-3262
- https://doi.org/10.1007/s11999-009-1039-8
Abstract
Bone morphogenic proteins (BMPs) are potent osteoinductive agents. Their use in fracture surgery is still being studied and the clinical indications are evolving. Heterotopic bone after BMP use in spine surgery is a known complication. While some literature describes the ability of BMP to enhance fracture healing, few articles describe complications of BMP. In tibial plateau fractures, after elevating the cartilage en mass, a subchondral void may be created in these fractures. Structural support provided by bone void-filling agents can be augmented with osteoinduction achieved by BMP. We asked whether heterotopic bone formation would occur more frequently with BMP-2 when used in tibial plateau fractures and whether BMP-2 enhanced the ability to maintain surgically restored subchondral bone integrity. Heterotopic bone developed more frequently in patients receiving BMP (10 of 17) than in patients not receiving BMP (one of 23). Four patients receiving BMP and no patients not receiving BMP underwent removal of heterotopic bone. Maintenance of subchondral bone integrity was similar without and with the use of BMP. BMP is a potent osteoinductive agent; however, when used for an off-label indication in periarticular situations, complications such as heterotopic bone are common and increase reoperation rates. Level of Evidence: Level IV, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.Keywords
This publication has 60 references indexed in Scilit:
- Improved Healing Efficacy in Canine Ulnar Segmental Defects With Increasing Recombinant Human Bone Morphogenetic Protein-2/Allograft RatiosJournal of Orthopaedic Trauma, 2008
- A Case of Psoas Ossification From the Use of BMP-2 for Posterolateral Fusion at L4–L5Spine, 2008
- A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft)International Orthopaedics, 2007
- Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineeringAdvanced Drug Delivery Reviews, 2007
- Staged reduction and stabilisation in chronic atlantoaxial rotatory fixationThe Journal of Bone and Joint Surgery, 2002
- Evaluation of recombinant human bone morphogenetic protein‐2 as a bone‐graft substitute in a canine segmental defect modelJournal of Orthopaedic Research, 2000
- Animal studies of application of rhBMP-2 in maxillofacial reconstructionBone, 1996
- Modifications of the hydrophilicity of heterocyclic methacrylate copolymers for protein releaseBiomaterials, 1995
- Degenerative Arthritis of the Knee Secondary to Fracture MalunionPublished by Ovid Technologies (Wolters Kluwer Health) ,1988
- Tibial Plateau Fractures An Analysis of the Results of Treatment in 60 PatientsClinical Orthopaedics and Related Research, 1984